Stock listing

NASDAQ:OPNT Opiant Pharmaceuticals Inc Stock

Follow Opiant Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:OPNT

$20.65 USD

Close on Mar 2, 2023 · No longer trades

Jan 5, 2015 to last close +313.0% · weekly closes, Jan 5, 2015 – Mar 2, 2023
Lowest – highest close
$3.35 – $50.50 USDSince Jan 5, 2015 · lowest Jan 15, 2015 · highest Sep 7, 2017

Delisted NASDAQ:OPNT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:OPNT
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Opiant Pharmaceuticals Inc on 6ix

Calls
5 calls with a replay · 5 with a transcript · latest Aug 11, 2022
Decks
5 decks · latest Feb 16, 2023

Events

Open Events

Decks

DeckKindSlidesDate
FY2022 Earnings PresentationEarnings19 slidesFeb 16, 2023
Merger or Acquisition (November 2022)Merger or acquisition17 slidesNov 15, 2022
Investor Presentation (September 2017)Investor deck39 slidesSep 12, 2017
Investor Presentation (April 2017)Investor deck34 slidesApr 19, 2017
Investor Presentation (September 2016)Investor deck27 slidesSep 13, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Richard J Daly
Other companies: Aquestive Therapeutics, Inc. (Director · Since at least Nov 10, 2026); Catalyst Pharmaceuticals, Inc. (President and CEO, Director · Since at least Dec 30, 2015); Palisade Bio, Inc. (Chief Executive Officer, Director · Feb 15, 2016 – Nov 7, 2017 · Past); Synergy Pharmaceuticals Inc (Director · Jun 30, 2015 – Jun 28, 2017 · Past)
Director · Jun 12, 2018 – Mar 2, 2023 · Past
Craig Collard
Other companies: Heron Therapeutics, Inc. (Chief Executive Officer · Since at least Feb 22, 2023); TerrAscend Corp. (Director · Since at least Jan 6, 2022); Sierra Oncology Inc (Director · May 26, 2020 – Jul 1, 2022 · Past)
Director · Jun 12, 2019 – Mar 2, 2023 · Past
Kevin Pollack
Other companies: Taronis Fuels Inc (Director · Mar 30, 2020 – Jan 7, 2021 · Past); Taronis Technologies Inc (Director · Apr 1, 2019 – Nov 21, 2019 · Past); Pressure BioSciences, Inc. (Director · Jul 3, 2012 – Mar 27, 2024 · Past)
See Remarks, Director · Apr 17, 2012 – Jan 13, 2017 · Past
Aziz Mottiwala
Other companies: RxSight, Inc. (President and Chief Executive Officer · Since at least Jul 20, 2026); Tarsus Pharmaceuticals, Inc. (Chief Commercial Officer · Since at least Oct 15, 2020)
Chief Commercial Officer · Sep 20, 2019 – Sep 20, 2019 · Past
Masuoka K Lorianne
Other companies: DiaMedica Therapeutics Inc. (Chief Medical Officer · Jan 22, 2024 – Jan 22, 2024 · Past); Marinus Pharmaceuticals Inc (Chief Medical Officer · Dec 6, 2017 – Aug 21, 2019 · Past)
Director · Mar 18, 2021 – Mar 2, 2023 · Past
Ann L MacDougall
Other companies: Progenics Pharmaceuticals Inc (Director · Dec 13, 2019 – Jun 19, 2020 · Past)
Director · Jun 12, 2019 – Mar 2, 2023 · Past
David O’Toole
Other companies: Avita Medical, Inc. (Chief Financial Officer · Since at least Jun 15, 2023)
Chief Financial Officer · Sep 12, 2017 – Mar 2, 2023 · Past
Roger Crystal
Other companies: Definium Therapeutics, Inc. (Compensation · Since at least Aug 11, 2022)
Chief Executive Officer, Director · Dec 10, 2014 – Mar 2, 2023 · Past
Geoffrey WolfDirector · Dec 10, 2014 – Dec 10, 2014 · Past
Mark Jason Heath EllisonChief Development Officer · Jan 26, 2021 – Mar 2, 2023 · Past
All 14 people
PersonSeat
Matthew R RuthChief Commercial Officer · Jul 19, 2021 – Mar 2, 2023 · Past
Michael SinclairDirector · May 18, 2012 – Mar 2, 2023 · Past
Phil SkolnickChief Scientific Officer · Apr 1, 2019 – Mar 2, 2023 · Past
Thomas T ThomasDirector · Jun 12, 2019 – Mar 2, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Opiant Pharmaceuticals Inc.